574 results on '"Hirsch, Etienne C."'
Search Results
2. Author Correction: Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
3. Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson’s disease
4. The specific NQO2 inhibitor, S29434, only marginally improves the survival of dopamine neurons in MPTP-intoxicated mice
5. Special issue in honor of Peter Riederer at the occasion of his 80th birthday
6. Neuroprotection of dopamine neurons by xenon against low-level excitotoxic insults is not reproduced by other noble gases
7. Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity
8. JNK-Mediated Induction of Cyclooxygenase 2 Is Required for Neurodegeneration in a Mouse Model of Parkinson's Disease
9. Dysfunction of mitochondrial Lon protease and identification of oxidized protein in mouse brain following exposure to MPTP: Implications for Parkinson disease
10. Nuclear Translocation of NF-κ B is Increased in Dopaminergic Neurons of Patients with Parkinson Disease
11. Effect of melatonin on sleep disorders in a monkey model of Parkinson's disease
12. Blood Vessels And Neurodegeneration In Parkinson’s Disease : Study in chronic MPTP-treated monkeys
13. Inflammatory Changes and Apoptosis in Parkinson’s Disease
14. Futures pistes thérapeutiques médicamenteuses pour la maladie de Parkinson
15. Mechanism and consequences of nerve cell death in Parkinson’s disease
16. Neuroinflammation in Parkinson's disease
17. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism
18. Neuronal vulnerability in Parkinson’s disease
19. Divalent Metal Transporter 1 (DMT1) Contributes to Neurodegeneration in Animal Models of Parkinson's Disease
20. Activation of the Subventricular Zone in Multiple Sclerosis: Evidence for Early Glial Progenitors
21. The pRb/E2F Cell-Cycle Pathway Mediates Cell Death in Parkinson's Disease
22. Localization and Density of Transferrin Binding Sites in the Nigrostriatal System of Control Subjects and Patients with Parkinson’s Disease
23. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinsonʼs disease
24. Sparing of orexin-A and orexin-B neurons in the hypothalamus and of orexin fibers in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated macaques
25. Neuroinflammation in Parkinson's disease: a target for neuroprotection?
26. Expression of Lactoferrin Receptors is Increased in the Mesencephalon of Patients with Parkinson Disease
27. Differences in Tyrosine Hydroxylase-Like Immunoreactivity Characterize the Mesostriatal Innervation of Striosomes and Extrastriosomal Matrix at Maturity
28. Selective Loss of Cholinergic Neurons in the Ventral Striatum of Patients with Alzheimer Disease
29. Neuronal Loss in the Pedunculopontine Tegmental Nucleus in Parkinson Disease and in Progressive Supranuclear Palsy
30. Decreased Choline Acetyltransferase mRNA Expression in the Nucleus Basalis of Meynert in Alzheimer Disease: An in situ Hybridization Study
31. Missing pieces in the Parkinson's disease puzzle
32. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease
33. Infiltration of [CD4.sup.+] lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease
34. Probenecid potentiates MPTP/MPP+ toxicity by interference with cellular energy metabolism
35. Pathogenesis of Parkinsonʼs disease
36. Normal and pathological gait: what we learn from Parkinsonʼs disease
37. Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
38. Quantitative evaluation of the human subventricular zone
39. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: A post-mortem study in human control subjects
40. Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
41. Dissociated mesencephalic cultures
42. Internal Pallidum and Substantia Nigra Control Different Parts of the Mesopontine Reticular Formation in Primate
43. Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice
44. Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease
45. Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson’s disease
46. Editorial
47. Neuroprotection of dopamine neurons by xenon against low-level excitotoxic insults is not reproduced by other noble gases
48. KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis
49. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication
50. Dysfunction of the subthalamic nucleus induces behavioral and movement disorders in monkeys
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.